PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25723C0042Radiopharmaceuticals — Alamo Nuclear Pharmacy Services Inc

Alamo Nuclear Pharmacy Services Inc holds — across 0 federal awards. Competition previously drew 3 offers. Set-aside status: NONE. PoP ended Mar 17, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

257-Network Contract Office 17 (36C257)

Awarding office

Alamo Nuclear Pharmacy Services Inc

Recipient

Mar 17, 2024

PoP end

$641K

Obligated

$3.2M

Potential

325412

NAICS

6505

PSC

NONE

Set-aside

3 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Alamo Nuclear Pharmacy Services Inc — $90

Contract facts

NONE

Contract number36C25723C0042

Also listed as36C257-23-C-0042

Agency257-Network Contract Office 17 (36C257)

Awarding office257-Network Contract Office 17 (36C257)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentAlamo Nuclear Pharmacy Services Inc

CAGE8DHG0

UEIC1P9SLFALM56

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Place of performanceSAN ANTONIO TX

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

Related solicitation36C25723Q0254

PoP startMar 18, 2023

PoP end (current)Mar 17, 2024

PoP end (w/ options)Mar 17, 2028

Obligated$641K

Current value$641K

Potential value$3.2M

RADIOPHARMACEUTICALS is a federal NONE award for 257-Network Contract Office 17 (36C257) held by Alamo Nuclear Pharmacy Services Inc. Estimated value $3.2M ($641K obligated). Current period of performance ends Mar 17, 2024 (potential Mar 17, 2028). Last award drew 3 bidders. Place of performance: SAN ANTONIO TX. Related solicitation 36C25723Q0254.

Recompete timing

Public

● Past PoP end (886 days ago)

Current PoP ended Mar 17, 2024 (886 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Alamo Nuclear Pharmacy Services Inc — — obligated across 0 awards (firm-wide, all agencies).

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25723C0042?

36C25723C0042 (Radiopharmaceuticals) is a 257-Network Contract Office 17 (36C257) award with a potential value of $3.2M, currently held by Alamo Nuclear Pharmacy Services Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C257-23-C-0042?

36C257-23-C-0042 is the dashed form of PIID 36C25723C0042 (Radiopharmaceuticals), held by Alamo Nuclear Pharmacy Services Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25723C0042?

257-Network Contract Office 17 (36C257) awarded 36C25723C0042 to Alamo Nuclear Pharmacy Services Inc (potential $3.2M).

Who is the incumbent on 36C25723C0042?

Alamo Nuclear Pharmacy Services Inc is the incumbent with — across 0 related awards in SCOUT’s public footprint. The current period of performance ends Mar 17, 2024.

When does Alamo Nuclear Pharmacy Services Inc’s 36C25723C0042 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 17, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 18, 2026 · refreshed monthlyLatest procurement action Mar 7, 2023